Inpatient and Outpatient Orderable

NASH FibroSure Plus Build info

Synonyms

  • NASH FIBROSURE
  • NONALCOHOLIC FATTY LIVER DISEASE
  • NASHFIBRO
  • LAB10822

Short Name

NASH FIBROSURE

Procedure Master Number

LAB10822

Procedure ID

114160

Clinical Info

This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD).
Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other 
liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune 
hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative
 predictions of fibrosis.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Red or Gold top tube
Specimen: 3.5 mL serum ( 2 mL min)
Transport Temperature: Refrigerated

Note: Patient should be fasting for at least eight hours
Causes for Rejection
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age

Transport Instructions

Refrigerated

Specimen Stability

3 Days Room Temperature or Refrigerated
7 Days Frozen

.

Methodology

The analytes tested are
performed by FibroSure-Specific methods.

Days Performed

Performing Laboratory

LabCorp

CPT

82172; 82247; 82465; 82947; 82977; 83010;
83883;  84450;  84460;  84478

PDM

 1559233

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
FIBROSIS SCORE. FIBROSIS FIBROSIS SCORE
FIBROSIS STAGE. FIBROSIS FIBROSIS STAGE
STEATOSIS SCORE STEATSC STEATOSIS SCORE Steatosis Score
STEATOSIS GRADE STEATGR STEATOSIS GRADE Steatosis Grade
NASH SCORE NASH NASH SCORE Nash Score
NASH GRADE NASH NASH GRADE Nash Grade
METHODOLOGY (LABCORP) METHOD METHODOLOGY LABCORP Methodology (Labcorp)
ALPHA 2-MACROGLOBULINS, QN A2MACROGLQN ALPHA 2 MACROGLOBULINS QN Alpha 2-Macroglobulins, Qn
HAPTOGLOBIN, SERUM HAPTOGLOBIN HAPTOGLOBIN Haptoglobin
APOLIPOPROTEIN A-1 APOA1 APOLIPOPROTEIN A 1
BILIRUBIN, TOTAL BILITOT BILIRUBIN TOTAL Total Bilirubin
GGT GGT GGT GGT
ALT (SGPT) P5P ALT ALT SGPT P5P Alt (Sgpt) P5P
AST (SGOT) P5P AST AST SGOT P5P AST (SGOT) P5P
CHOLESTEROL, TOTAL. CHOL CHOLESTEROL, TOTAL Cholesterol, Total.
GLUCOSE, SERUM GLU GLUCOSE Glucose
TRIGLYCERIDES. TRIG TRIGLYCERIDES Triglycerides
INTERPRETATIONS INTERP INTERPRETATIONS Interpretations
FIBROSIS SCORING: FIBROSISSCR FIBROSIS SCORING Fibrosis Scoring:
STEATOSIS SCORING STEATOSISSC STEATOSIS SCORING Steatosis Scoring
NASH SCORING NASH NASH SCORING Nash Scoring
LIMITATIONS LIMITA LIMITATIONS Limitations
ADDITIONAL COMMENT:. COMMENT ADDITIONAL COMMENT Additional Comment:.
COMMENT:. COMMENT COMMENT